Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Application save search
Everest Medicines Announces New Drug Application Acceptance of Nefecon® in Taiwan for the Treatment of Primary IgA Nephropathy in Adult Patients
Published: 2023-12-27 (Crawled : 05:00) - prnewswire.com
CALT | $18.5 1.65% 1.62% 1K
|
Health Technology
|
| O: -3.52%
H: 1.97%
C: 1.89%
nefecon nephropathy drug treatment application
Milestone Pharmaceuticals Receives Refusal to File Letter from U.S. FDA for New Drug Application for Etripamil in the Treatment of PSVT
Published: 2023-12-26 (Crawled : 12:00) - globenewswire.com
MIST | $1.66 -2.35% -1.8% 49K
|
Health Technology
|
| O: -30.56%
H: 3.0%
C: -0.5%
etripamil fda drug treatment pharmaceuticals application milestone
Senti Bio Announces FDA Clearance of IND Application for SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia
Published: 2023-12-22 (Crawled : 12:00) - globenewswire.com
SNTI | $0.2809 -6.37% -9.04% 52K
|
Health Technology
|
| O: 28.06%
H: 6.72%
C: -7.51%
senti-202 fda treatment clearance application leukemia
Zealand Pharma submits New Drug Application to the US FDA for glepaglutide in short bowel syndrome
Published: 2023-12-22 (Crawled : 10:00) - globenewswire.com
ZEAL | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
fda pharma drug application
Great Lakes Dredge & Dock Co. Announces Significant Status Update on its Maritime Administration (“MARAD”) Title XI Financing Application
Published: 2023-12-21 (Crawled : 21:00) - globenewswire.com
GLDD 4 | $7.44 -2.49% -2.42% 230K
|
Industrial Services
|
| O: 1.74%
H: 0.79%
C: 0.26%
maritime update application
Johnson & Johnson Submits Supplemental Biologics License Application and New Drug Application to U.S. FDA Seeking Approval of RYBREVANT® (amivantamab-vmjw) Plus Lazertinib for the Treatment of Patients with EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC)
Published: 2023-12-21 (Crawled : 13:00) - prnewswire.com
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: -1.87%
H: 0.0%
C: 0.0%
rybrevant fda lung drug license approval cancer cell treatment application plus
Gracell Biotechnologies Announces China NMPA Clearance for IND Application for Phase 1/2 Clinical Trial of FasTCAR-T GC012F for the Treatment of Refractory Systemic Lupus Erythematosus
Published: 2023-12-21 (Crawled : 12:00) - globenewswire.com
GRCL | $10.25 -0.29% 6.4M
|
Manufacturing
|
| O: 2.64%
H: 5.48%
C: 3.06%
gc012 biotechnologies lupus treatment clearance application trial china
Aurinia Submits IND Application to US Food & Drug Administration for AUR 200
Published: 2023-12-20 (Crawled : 11:00) - ir.auriniapharma.com
AUPH | $5.03 -1.18% -1.19% 790K
|
Health Technology
|
| O: -1.05%
H: 0.96%
C: -5.11%
drug food application
Anavex Received Agreement from the Committee for Medicinal Products for Human Use (CHMP) for the Submission of a Marketing Authorisation Application of Oral Blarcamesine for Alzheimer’s Disease
Published: 2023-12-19 (Crawled : 12:30) - globenewswire.com
AVXL | $3.41 -7.34% -8.24% 1.7M
|
Health Technology
|
| O: 2.39%
H: 16.11%
C: 10.56%
disease blarcamesine alzheimer’s application anavex agreement submission
Sunrise New Energy Announces Patent Application for Multivariable Particle Size Control System for Graphite Micropowder Production Accepted by the National Intellectual Property Bureau
Published: 2023-12-18 (Crawled : 15:00) - globenewswire.com
EPOW | $0.71 -5.43% -4.4% 8.8K
|
Administrative and Support and ...
|
| O: 3.88%
H: 14.95%
C: 12.15%
patent energy control system application
NRx Pharmaceuticals Announces FDA Clearance of its Investigational New Drug (IND) Application for NRX-101 in the Treatment of Complicated Urinary Tract Infections
Published: 2023-12-18 (Crawled : 14:00) - biospace.com/
NRXP 5 d | $3.12 2.3% 1.93% 98K
|
Manufacturing
|
| O: 29.38%
H: 8.76%
C: -4.01%
nrx-101 fda drug treatment clearance pharmaceuticals application infections
Positive opinion from ISA-Israel patent office Provides the ability to file a patent application under the Patent Prosecution Highway (PPH) in the US
Published: 2023-12-18 (Crawled : 13:30) - globenewswire.com
BCAN | $0.9484 -2.23% -1.73% 900K
|
Construction
|
| O: 3.5%
H: 3.52%
C: -4.76%
patent positive application
Wearable Devices Sets New Standard in AR/VR Era with U.S Patent Application for Innovative Touchless Technology
Published: 2023-12-18 (Crawled : 13:00) - globenewswire.com
WLDS | $0.463 -2.53% 2.86% 71K
|
|
| O: 4.48%
H: 1.66%
C: -4.46%
patent application technology
Catalyst Pharmaceuticals Announces FIRDAPSE® New Drug Application Submitted in Japan by Partner DyDo Pharma
Published: 2023-12-18 (Crawled : 12:00) - globenewswire.com
CPRX | News | $15.12 2.65% 2.58% 720K
|
Health Technology
|
| O: 0.63%
H: 0.02%
C: -2.56%
firdapse pharma drug japan pharmaceuticals application
Saudi Arabia Conversational Commerce Market Intelligence Report 2023: 75+ KPIs on End-Use Sectors, Operational KPIs, Product Offering, and Application Spend 2019-2028
Published: 2023-12-16 (Crawled : 04:20) - prnewswire.com
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $94.0 -0.27% -2.18% 310
|
Health Technology
| Email alert
Add to watchlist
report intelligence application market
Duke Energy responds to constructive North Carolina Utilities Commission decision on Duke Energy Carolinas' Performance-Based Regulation Application
Published: 2023-12-15 (Crawled : 00:20) - prnewswire.com
DUK | News | $98.96 0.77% 0.06% 1.7M
|
Utilities
| Email alert
Add to watchlist
energy application
Century Aluminum Applauds Treasury Guidance on 45X Clarifying Application to U.S. Primary Aluminum Industry
Published: 2023-12-15 (Crawled : 21:00) - globenewswire.com
CENX | $17.39 -0.91% -0.98% 890K
|
Non-Energy Minerals
| Email alert
Add to watchlist
application
Infor Named a Leader in 2023 Gartner Magic Quadrant for Configure, Price and Quote Application Suites
Published: 2023-12-15 (Crawled : 14:00) - prnewswire.com
IT | $451.06 0.18% 0.0% 280K
|
Commercial Services
|
| O: -1.01%
H: 1.26%
C: -1.11%
gartner application
CymaBay Submits New Drug Application to FDA for Seladelpar for the Treatment of Primary Biliary Cholangitis
Published: 2023-12-15 (Crawled : 13:00) - prnewswire.com
CBAY | $32.48 0.03% 8.4M
|
Health Technology
|
| O: 0.35%
H: 0.0%
C: 0.0%
fda drug treatment application
Global Application Performance Management (APM)Market Analysis Report 2023-2030: Rising Significance of Cloud-based APM, Shifting of Load Testing to Cloud, The AI Edge to APMs, The Emergence of AIOps
Published: 2023-12-14 (Crawled : 18:00) - prnewswire.com
AKAM | $102.19 0.42% 0.42% 790K
|
Technology Services
|
| O: 0.13%
H: 1.71%
C: 0.58%
ADBE A | $477.12 0.89% 0.96% 1.7M
|
Technology Services
|
| O: -5.01%
H: 0.03%
C: -1.41%
management report global application
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.